{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:41Z","timestamp":1707524561324},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,24]]},"DOI":"10.7759\/cureus.25285","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T13:31:53Z","timestamp":1653399113000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case Report of Hypophosphatemia Leading to the Diagnosis of Mesothelioma"],"prefix":"10.7759","author":[{"given":"Zi W","family":"Goh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30426-7","article-title":"Approach to patients with hypophosphataemia","volume":"8","author":"Florenzano P","year":"2020","unstructured":"Florenzano P, Cipriani C, Roszko KL, Fukumoto S, Collins MT, Minisola S, Pepe J. Approach to patients with hypophosphataemia. Lancet Diabetes Endocrinol. 2020, 8:163-74.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0124","article-title":"Hypophosphatemia: an evidence-based approach to its clinical consequences and management","volume":"2","author":"Amanzadeh J","year":"2006","unstructured":"Amanzadeh J, Reilly RF Jr. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol. 2006, 2:136-48. 10.1038\/ncpneph0124","journal-title":"Nat Clin Pract Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0004563214521399","article-title":"Phosphate homeostasis and disorders","volume":"51","author":"Manghat P","year":"2014","unstructured":"Manghat P, Sodi R, Swaminathan R. Phosphate homeostasis and disorders. Ann Clin Biochem. 2014, 51:631-56. 10.1177\/0004563214521399","journal-title":"Ann Clin Biochem"},{"key":"ref4","article-title":"Hypophosphatemia: evaluation and treatment","author":"Yu ASL","year":"2020","unstructured":"Yu ASL, Stubbs JR. Hypophosphatemia: evaluation and treatment. UpToDate. TW Post (ed): UpToDate, Waltham, MA; 2020."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X18779761","article-title":"Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm","volume":"10","author":"Day AL","year":"2018","unstructured":"Day AL, Morgan SL, Saag KG. Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm. Ther Adv Musculoskelet Dis. 2018, 10:151-6. 10.1177\/1759720X18779761","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe AL","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, et al.. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004, 28:1-30. 10.1097\/00000478-200401000-00001","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000460","article-title":"Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia","volume":"40","author":"Agrawal K","year":"2015","unstructured":"Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, Bhansali A. Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med. 2015, 40:e6-e10. 10.1097\/RLU.0000000000000460","journal-title":"Clin Nucl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1066896915617828","article-title":"FGF23-associated tumor-induced osteomalacia in a patient with small cell carcinoma: a case report and regulatory mechanism study","volume":"24","author":"Sauder A","year":"2016","unstructured":"Sauder A, Wiernek S, Dai X, et al.. FGF23-associated tumor-induced osteomalacia in a patient with small cell carcinoma: a case report and regulatory mechanism study. Int J Surg Pathol. 2016, 24:116-20. 10.1177\/1066896915617828","journal-title":"Int J Surg Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84638-a-case-report-of-hypophosphatemia-leading-to-the-diagnosis-of-mesothelioma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:22Z","timestamp":1707507802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84638-a-case-report-of-hypophosphatemia-leading-to-the-diagnosis-of-mesothelioma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.25285","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,24]]}}}